CC
APTO

Carlson Capital’s Aptose Biosciences, Inc. APTO Stock Holding History

Carlson Capital’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,222
Closed -$246K – 165
2023
Q4 		$246K Sell
3,222
-334
-9% -$25.9K 0.02% 119
2023
Q3 		$299K Hold
3,556
– – 0.02% 129
2023
Q2 		$495K Sell
3,556
-111
-3% -$23K 0.04% 109
2023
Q1 		$1.06M Sell
3,667
-689
-16% -$200K 0.1% 98
2022
Q4 		$1.14M Sell
4,356
-111
-2% -$29.8K 0.09% 103
2022
Q3 		$1.2M Buy
4,467
+228
+5% +$78.6K 0.09% 103
2022
Q2 		$1.42M Buy
4,239
+762
+22% +$365K 0.1% 109
2022
Q1 		$2.13M Buy
3,477
+366
+12% +$202K 0.15% 121
2021
Q4 		$1.89M Buy
3,111
+1,510
+94% +$1.42M 0.11% 120
2021
Q3 		$1.57M Buy
1,601
+468
+41% +$585K 0.08% 143
2021
Q2 		$1.69M Buy
1,133
+244
+27% +$532K 0.08% 136
2021
Q1 		$2.39M Buy
889
+333
+60% +$660K 0.09% 140
2020
Q4 		$1.09M Buy
+556
New +$1.31M 0.04% 144

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.52B AUM 18.08% 1-Year Est. Return

Carlson Capital's APTO Position: Q1 2024 in Review

Carlson Capital sold out of Aptose Biosciences, Inc. (APTO) in Q1 2024, closing a stake of 3,222 shares — an estimated $246K sold.

Carlson Capital first reported a position in APTO in Q4 2020 and held it in 13 quarters. The position peaked at $2.39M in Q1 2021. 24 funds tracked by Wall St. Rank hold APTO as of Q1 2024.

  • Carlson Capital reported no remaining Aptose Biosciences, Inc. position as of Q1 2024 after selling out during the quarter.
  • Carlson Capital sold 3,222 Aptose Biosciences, Inc. shares in Q1 2024, an estimated $246K.
  • Carlson Capital first reported a position in Aptose Biosciences, Inc. in Q4 2020 and held it in 13 quarters.
  • Carlson Capital's Aptose Biosciences, Inc. position peaked at $2.39M in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2024.

Based on Carlson Capital's 13F filing for Q1 2024, filed 14 May 2024.